Impact of using time-averaged exposure metrics on binary endpoints in exposure-response analyses Blog Post
Abstract This Frontiers in Pharmacology article investigates how using different time-averaged exposure metrics, specifically the time-averaged concentration to event (CavTE), impacts exposure-response (ER) analyses, particularly when using logistic regression with...
Model-Informed Drug Development: Current Landscape and Future Directions Blog Post
日付：2025年2月25日 (火曜日) Time: 5:30 - 8:00pm Venue: CIC Cambridge - One Broadway, Cambridge, MA 02142 Summary Join us for an interactive event focused on Model-Informed Drug Development...
Anonymization vs. Redaction of Clinical Trial Data Blog Post
Honz Slipka 2025年1月17日 The vernacular for disclosing pharmaceutical clinical trial results to the public may seem just as confusing as the process! Some people use “anonymization” and “redaction”...
Management of Vulnerable Patients Hospitalized for COVID-19 With Remdesivir: A Retrospective Comparative Effectiveness Study of Mortality in US Hospitals Blog Post
Abstract Background Coronavirus disease 2019 (COVID-19) remains a major public health concern, with continued resurgences of cases and substantial risk of mortality for hospitalized patients. Remdesivir has become standard-of-care for...
Dose Guidance for a Novel Combination Therapy to Treat Head and Neck Squamous Cell Carcinoma (HNSCC) for Patients with HRAS/PIK3CA Variants Using a Quantitative Systems Pharmacology (QSP) Model Blog Post
Download PDF You May Also Like AllModeling and Simulation - QSP A minimal physiologically-based pharmacokinetic/pharmacodynamic mouse xenograft model to inform the evaluation of 212Pb-based Radio-DARPins targeting DLL3A minimal physiologically-based pharmacokinetic/pharmacodynamic...
Certara Reports Preliminary Fourth Quarter and Full Year 2024 Financial Results Blog Post
2025年1月15日 Full-Year 2024 Revenue of $384.4 million, Bookings of $445.3 million Confirms Adjusted EBITDA within Guidance Range of $120 million to $124 million RADNOR, PA — 2025年1月15日...
Phoenix in the Future: Unveiling the Product Roadmap and the New TFL Module [APAC Webinar] Blog Post
Kristin Follman, PhD Principal Research Scientist Dr. Kristin Follman is a Principal Research Scientist at Certara, where she is a member of the team building the TFL module. 彼女はバッファロー大学で...
Achieve Clinical Data Transparency with the 4 Cs of Collaboration Blog Post
In this blog, we look at how you can enhance clinical data transparency and make data informed decisions with the 4 Cs of collaboration.
